Literature DB >> 12551745

The collagenolytic effects of the traditional Chinese medicine preparation, Han-Dan-Gan-Le, contribute to reversal of chemical-induced liver fibrosis in rats.

Chengxiu Li1, Jun Luo, Ling Li, Mingliang Cheng, Nenghui Huang, Jie Liu, Michael P Waalkes.   

Abstract

Han-Dan-Gan-Le (HDGL), a Chinese herb preparation composed of Stephaniat tetrandra, Salvia miltorrhiza, Radix paeoniae, Astragalus membranaceus, and Ginkgo biloba, has been used to treat human liver fibrosis. This study was designed to examine the therapeutic effect of HDGL on chemical-induced liver fibrosis in adult Wistar rats. Liver fibrosis was produced in rats by carbon tetrachloride (1.2 ml CCl(4)/kg, 2 times/week, after an initial dose of 5.0 ml CCl(4)/kg, sc), plus a diet of 20% fat, 0.05% cholesterol (continuous) and 30% alcohol in the drinking water ad libitum (every other day) for 8 weeks. HDGL (0.5 and 1.0 g/kg, ig, daily for 6 weeks) was administered to rats 72 hrs after the last dose of CCl(4) to examine its therapeutic effects on chemical-induced liver fibrosis. Upon pathological examination, the HDGL treatment had significantly reversed chemical-induced liver fibrosis and other hepatic lesions. Hepatic collagen accumulation induced by CCl(4) was markedly reduced by HDGL treatment, as evidenced by hepatic collagen content and by immunohistochemical analysis of type-I collagen in liver. HDGL appeared to stimulate the collagenolytic process in the liver, as a 30-50% increase in urinary excretion of hydroxyproline was observed with HDGL treatment as compared to rats only given CCl(4). In conclusion, HDGL can effectively reverse chemically induced liver fibrosis, and this appears to be due, at least in part, to the stimulation of hepatic collagenolysis, resulting in a resolution of hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551745     DOI: 10.1016/s0024-3205(02)02448-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Effects of Shenqi Neijin powder on activation and apoptosis of hepatic stellate cells in rats with hepatic fibrosis.

Authors:  Hongdong Xie; Wei Hou; Yide Yang; Ying Yu; Fengling Wang; Juanjuan Mao
Journal:  Int J Clin Exp Med       Date:  2015-01-09

2.  Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis.

Authors:  Abdullah Saad Abdullah; Ibrahim El Tantawy El Sayed; Abdel Moneim A El-Torgoman; Abul Kalam; S Wageh; Maher A Kamel
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

3.  Urine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach.

Authors:  Xiaojun Gou; Qing Tao; Qin Feng; Jinghua Peng; Yu Zhao; Jianye Dai; Wenyu Wang; Yongyu Zhang; Yiyang Hu; Ping Liu
Journal:  BMC Complement Altern Med       Date:  2013-06-03       Impact factor: 3.659

4.  Chinese medicines as a resource for liver fibrosis treatment.

Authors:  Yibin Feng; Kwok-Fan Cheung; Ning Wang; Ping Liu; Tadashi Nagamatsu; Yao Tong
Journal:  Chin Med       Date:  2009-08-20       Impact factor: 5.455

5.  Protective effects of extracts from Pomegranate peels and seeds on liver fibrosis induced by carbon tetrachloride in rats.

Authors:  Xiang-Lan Wei; Ru-Tang Fang; Yong-Hua Yang; Xue-Yuan Bi; Guo-Xia Ren; A-Li Luo; Ming Zhao; Wei-Jin Zang
Journal:  BMC Complement Altern Med       Date:  2015-10-27       Impact factor: 3.659

6.  Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.

Authors:  Yuanyuan Wang; Rong Wang; Yujie Wang; Ruqin Peng; Yan Wu; Yongfang Yuan
Journal:  Drug Des Devel Ther       Date:  2015-12-03       Impact factor: 4.162

7.  Preparation and Characterization of Silymarin-Conjugated Gold Nanoparticles with Enhanced Anti-Fibrotic Therapeutic Effects against Hepatic Fibrosis in Rats: Role of MicroRNAs as Molecular Targets.

Authors:  Abdullah Saad Abdullah; Ibrahim El Tantawy El Sayed; Abdel Moneim A El-Torgoman; Noweir Ahmad Alghamdi; Sami Ullah; S Wageh; Maher A Kamel
Journal:  Biomedicines       Date:  2021-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.